Literature DB >> 24428662

A poly-γ-(D)-glutamic acid depolymerase that degrades the protective capsule of Bacillus anthracis.

David Negus1, Peter W Taylor.   

Abstract

A mixed culture of Pseudomonas fluorescens and Pusillimonas noertemanii, obtained by soil enrichment, elaborated an enzyme (EnvD) which rapidly hydrolysed poly-γ-d-glutamic acid (PDGA), the constituent of the anti-phagocytic capsule conferring virulence on Bacillus anthracis. The EnvD gene is carried on the P. noertemanii genome but co-culture is required for the elaboration of PDGA depolymerase activity. EnvD showed strong sequence homology to dienelactone hydrolases from other Gram-negative bacteria, possessed no general protease activity but cleaved γ-links in both d- and l-glutamic acid-containing polymers. The stability at 37°C was markedly superior to that of CapD, a γ-glutamyltranspeptidase with PDGA depolymerase activity. Recombinant EnvD was recovered from inclusion bodies in soluble form from an Escherichia coli expression vector and the enzyme stripped the PDGA capsule from the surface of B. anthracis Pasteur within 5 min. We conclude from this in vitro study that rEnvD shows promise as a potential therapeutic for the treatment of anthrax.
© 2014 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24428662     DOI: 10.1111/mmi.12523

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  6 in total

1.  Parenteral Administration of Capsule Depolymerase EnvD Prevents Lethal Inhalation Anthrax Infection.

Authors:  David Negus; Julia Vipond; Graham J Hatch; Emma L Rayner; Peter W Taylor
Journal:  Antimicrob Agents Chemother       Date:  2015-10-05       Impact factor: 5.191

Review 2.  The past, present, and future of enzyme-based therapies.

Authors:  Jennifer N Hennigan; Michael D Lynch
Journal:  Drug Discov Today       Date:  2021-09-16       Impact factor: 7.851

3.  Therapeutic Application of Phage Capsule Depolymerases against K1, K5, and K30 Capsulated E. coli in Mice.

Authors:  Han Lin; Matthew L Paff; Ian J Molineux; James J Bull
Journal:  Front Microbiol       Date:  2017-11-16       Impact factor: 5.640

Review 4.  Enhancing Whole Phage Therapy and Their Derived Antimicrobial Enzymes through Complex Formulation.

Authors:  Callum J Cooper; Shazeeda Koonjan; Anders S Nilsson
Journal:  Pharmaceuticals (Basel)       Date:  2018-04-19

Review 5.  The Bacillus anthracis Cell Envelope: Composition, Physiological Role, and Clinical Relevance.

Authors:  Alice Chateau; Sander E Van der Verren; Han Remaut; Antonella Fioravanti
Journal:  Microorganisms       Date:  2020-11-26

6.  Characterisation of Bacteriophage-Encoded Depolymerases Selective for Key Klebsiella pneumoniae Capsular Exopolysaccharides.

Authors:  George Blundell-Hunter; Mark C Enright; David Negus; Matthew J Dorman; Gemma E Beecham; Derek J Pickard; Phitchayapak Wintachai; Supayang P Voravuthikunchai; Nicholas R Thomson; Peter W Taylor
Journal:  Front Cell Infect Microbiol       Date:  2021-06-18       Impact factor: 5.293

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.